About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
Product
Crystal form
Current batch size
USDMF
EUDMF
21
Elagolix Sodium
Amorphous
101-113.5kg
USDMF36738
EUDMF
22
Eltrombopag Olamine
Form Ⅰ
17.5-19.7kg
USDMF37134
EUDMF
23
Enalaprilat
450G-550G
24
Etelcalcetide
Amorphous
1~3Kg
25
Etrasimod
L-Arginine Salt/ Reported in Compound patent
10-15 kg
26
Ezetimibe
Form A
4.3-173.6kg
USDMF24511 (ZTB) /35963 (ZT)
EUDMF
27
Finerenone
Form I
70-75kg
DMF will be ready within March,2024
28
Folic Acid
40kg
29
Hydrochlorothiazide
1000kg
USDMF16750
EUDMF/CEP 2006-011
30
LCZ696 (Sacubitril + Valsartan)
Form A
164.3-181kg
USDMF35480
EUDMF
31
Ledipasvir Actone /PVP
Form II /Amorphous
10-50kg (pilot)
DMF
32
Lenalidomide
Form A
6-10kg
USDMF31804
EUDMF
33
Niraparib tosylate monohydrate
Form I
25-28Kg
USDMF
34
Obeticholic Acid
Amorphous
16.5-18.7kg
USDMF37355
35
Oteseconazole
Anhydrous crystalline form
2-3Kg
36
Pitavastatin Calcium
37
Pomalidomide
Form A
5.2-10.8kg
DMF
38
Pregabalin
As Innovator
150kg/925kg
USDMF22223
EUDMF/CEP 2016-141
39
Relugolix
Anhydrous Non-solvent Form
17-19kg
DMF
40
Remdesivir
DMF
1
2
3
4
Leave Your Message
SAND OUT